July 23, 2025

Ultrasound Combo Detects MASH and Fibrosis

Two ultrasound techniques show strong diagnostic performance for steatohepatitis and fibrosis, supporting a noninvasive alternative to biopsy.

Conexiant

July 21, 2025

Sharp Rise in Fentanyl Overdoses During Pandemic

From 2019 to 2021, U.S. emergency departments saw a 125.4% rise in synthetic opioid overdoses, highlighting shifting trends in hospital use related to opioids during and before the COVID-19 pandemic.

Conexiant

July 21, 2025

Preeclampsia Risk Scores Under USPSTF Lack Precision, Study Finds

Researchers found that USPSTF guidelines inadequately stratify preeclampsia risk among pregnant patients, particularly those at moderate risk, and therefore limit the utility of aspirin prophylaxis recommendations.

Conexiant

July 18, 2025

Later Eating Linked to Insulin Resistance

A twin study found that individuals who consumed most of their daily calories later in their personal circadian rhythm had lower insulin sensitivity and greater insulin resistance, with genetics playing a role in meal timing behavior.

Conexiant

July 18, 2025

Blood Test Predicts Organ Aging and Mortality

Researchers used blood proteins to estimate the biological age of 11 organs in over 44,000 people, revealing that older brain and immune systems were linked to higher disease and death risks, while younger ones predicted longer life.

Conexiant

July 17, 2025

Once-Weekly Insulin Effective and Safe Alternative to Daily Dosing

A 78-week international trial found that a once-weekly insulin injection effectively lowered blood sugar in adults with type 2 diabetes, performing similarly to a once-daily insulin regimen with comparable safety.

Conexiant

July 17, 2025

Vapes Outperform Nicotine Replacement Therapy in Cessation Trial

Researchers found vaporized nicotine products more effective than nicotine replacement therapy for smoking cessation among socioeconomically disadvantaged adults.

Conexiant

July 17, 2025

Semaglutide, Tirzepatide Linked to Lower Dementia Risk

Researchers found that semaglutide and tirzepatide were associated with reduced risks of dementia, stroke, and all-cause mortality in patients with type 2 diabetes and obesity.

Conexiant

July 17, 2025

Hormone Therapy Type Tied to Diverging Risks of Breast Cancer Before Age 55

Researchers found that unopposed estrogen therapy was linked to reduced young-onset breast cancer risk, while estrogen plus progestin therapy increased risk in certain subgroups.

Conexiant